Abstract
The natriuretic peptides, B-type natriuretic peptide (BNP) and amino-terminal pro-B-type natriuretic peptide (NT-proBNP), are biomarkers of neurohormonal activation related to heart failure (HF) severity and associated with adverse outcomes and poor prognosis in HF patients with rising levels (1-3).
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
